Securities Class Actions and Derivative Litigation: Two For the Price of One
December 4, 2007
The cost of resolving securities class actions has reached an all time high. While new filings are at their lowest since enactment of the PSLRA, that is small consolation to the company having the misfortune of being the target of this type of lawsuit. Not only must the company defend against the class action, it must also resist the tag-along derivative action that has become all too commonplace. This session discussed how this works and the key role of Directors and Officers (D&O) insurance.
Presenters included: Richard S. Davis, Foley & Lardner LLP; Michael Early, Chicago Underwriting Group; and Michael P. McCloskey, Foley & Lardner LLP.
Related Insights
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.
June 4, 2025
Energy Current
Nuclear’s Comeback: What Renewables Professionals Should Know
The clean energy transition isn’t a zero-sum game – it’s a team effort. And one player is stepping back into the spotlight with renewed…
June 4, 2025
Foley Ignite
M&A Disputes Set to Rise in Latin America: How Savvy Investors Are Protecting Themselves
As deal activity shows signs of rebounding in 2025, investors are bracing for an increase in M&A-related disputes globally, and Latin…